We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Targeting Tumors: Challenges of Antibody-Drug Conjugates

Video   Jun 12, 2018 | Nature Video, YouTube

 

Treating cancer requires aggressive but targeted therapy. Some cancer drugs are too toxic because they damage healthy cells as well as tumor cells. So researchers are trying to develop ways to make sure drugs only target the right cells.

One solution is to attach drugs to antibodies specific to a protein expressed on tumor cells. These drugs are called antibody-drug conjugates (ADCs).

More than two dozen ADCs are currently being used in the clinic to treat diseases like Hodgkin's lymphoma and breast cancer, and researchers are developing many more. But it's taken decades to find the right combination of drug, antibody target and linker, and then make sure the right amount of ADC hits the tumor. 


 
More Information
 
 
 

Recommended Videos

Mya 4 Reaction Station from Radleys - safe, unattended chemistry round the clock - one Reaction Station with limitless possibilities (full demonstration)

Video

A 4-zone reaction station from Radleys, offering safe and precise heating, active cooling, software control and data-logging for 24/7 unattended chemistry.

WATCH NOW

CAR T-Cell Therapy | FAQ with Dr. Patrick Brown

Video

Find out about why there is so much excitement about this new therapy, which patients are the best candidates, as well as CAR T-cell effectiveness, safety, and costs.

WATCH NOW

The Mugshot of Cancer | Joshua LaBaer | TEDxASU

Video

Dr. Joshua LaBaer discusses a novel method invented in his lab to identify cancer and how we can use this to save lives of millions of people.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE